Diaceutics (LON:DXRX) Trading Up 0.8% – Here’s What Happened

Diaceutics PLC (LON:DXRX) traded up 0.8% on Monday . The stock traded as high as GBX 128.25 ($1.67) and last traded at GBX 128.25 ($1.67). 58,412 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 126,544 shares. The stock had previously closed at GBX 127.20 ($1.65).

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($2.08) price target on shares of Diaceutics in a report on Tuesday, December 17th. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($2.08) price target on shares of Diaceutics in a report on Tuesday, December 17th.

Diaceutics Price Performance

The firm has a fifty day simple moving average of GBX 139.58 and a 200 day simple moving average of GBX 130.50. The company has a market capitalization of £105.49 million, a PE ratio of -37.07 and a beta of 0.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85.

Insiders Place Their Bets

In related news, insider Graham Paterson purchased 11,643 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were acquired at an average cost of GBX 138 ($1.79) per share, for a total transaction of £16,067.34 ($20,888.38). 34.30% of the stock is currently owned by company insiders.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.